Query String: Chloroform fraction from Actinidia arguta

  • (4-{3-[1-(3-Aminomethyl-benzylcarbamoyl)-3-methyl-butylcarbamoyl]-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl}-1-benzyl-butyl)-carbamic acid tert-butyl ester : (0.6 chloroform) CHEMBL352450 BDBM50016037
  • BDBM50016040 CHEMBL435076 {1-Benzyl-4-[3-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl]-but-2-enyl}-carbamic acid tert-butyl ester : (0.1 chloroform)
  • BDBM50016060 {1-Benzyl-4-[1-benzyl-3-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-2-hydroxy-propylcarbamoyl]-but-2-enyl}-carbamic acid tert-butyl ester : (0.2 chloroform) CHEMBL168819
  • CHEMBL167204 (1-Benzyl-4-{1-[2-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-hydroxy-ethyl]-3-methyl-butylcarbamoyl}-butyl)-carbamic acid tert-butyl ester : (0.2 chloroform) BDBM50016041
  • {1-Benzyl-4-[3-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl]-2-hydroxy-butyl}-carbamic acid tert-butyl ester : (0.45 chloroform) BDBM50016025 CHEMBL354821
  • [1-(3-{[3-(1-Benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl]-methyl}-oxiranyl)-2-phenyl-ethyl]-carbamic acid tert-butyl ester : (0.7 chloroform) BDBM50016032 CHEMBL353204
  • (1-Benzyl-4-{1-[2-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-hydroxy-ethyl]-3-methyl-butylcarbamoyl}-2,3,4-trihydroxy-butyl)-carbamic acid tert-butyl ester : (0.25 chloroform) CHEMBL354147 BDBM50016031
  • (4-{3-[1-(4-Aminomethyl-benzylcarbamoyl)-3-methyl-butylcarbamoyl]-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl}-1-benzyl-2-hydroxy-butyl)-carbamic acid tert-butyl ester : (0.5 chloroform) BDBM50016034 CHEMBL423262
  • CHEMBL168302 (4-{1-[2-(1-Benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-hydroxy-ethyl]-3-methyl-butylcarbamoyl}-1-cyclohexylmethyl-2,3-dihydroxy-butyl)-carbamic acid tert-butyl ester : (0.25 chloroform) BDBM50016054
  • CHEMBL350359 BDBM50016027 3-Hydroxy-6-methyl-4-(2-{3-[1-(3-methyl-butyrylamino)-2-phenyl-ethyl]-oxiranyl}-acetylamino)-heptanoic acid (1-benzylcarbamoyl-3-methyl-butyl)-amide : (0.1 chloroform)
  • CHEMBL354969 (1-Benzyl-4-{1-[2-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-hydroxy-ethyl]-3-methyl-butylcarbamoyl}-2,3-dihydroxy-butyl)-carbamic acid tert-butyl ester : (0.3 chloroform) BDBM50016066
  • {1-Benzyl-4-[3-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl]-2-hydroxy-but-3-enyl}-carbamic acid tert-butyl ester : (0.25 chloroform) CHEMBL167426 BDBM50016046
  • CHEMBL167218 {1-[3-({3-[1-(3-Aminomethyl-benzylcarbamoyl)-3-methyl-butylcarbamoyl]-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl}-methyl)-oxiranyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester : (0.9 chloroform) BDBM50016042
  • CHEMBL424536 (4-{1-[2-(1-Benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-hydroxy-ethyl]-3-methyl-butylcarbamoyl}-1-isobutyl-2-oxo-5-phenyl-pentyl)-carbamic acid benzyl ester : (0.05 chloroform) BDBM50016057
  • BDBM50016067 [1-Benzyl-4-(3-{1-[4-(benzyloxycarbonylamino-methyl)-benzylcarbamoyl]-3-methyl-butylcarbamoyl}-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl)-2-hydroxy-but-3-enyl]-carbamic acid tert-butyl ester : (0.45 chloroform) CHEMBL435266
  • {1-Benzyl-2-[1-[1-benzyl-3-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-2-hydroxy-propylcarbamoyl]-2-(1H-imidazol-4-yl)-ethylamino]-ethyl}-carbamic acid tert-butyl ester : (0.2 chloroform) BDBM50016021 CHEMBL354767
  • {1-Benzyl-2-[1-{1-[2-(1-benzylcarbamoyl-3-methyl-butylcarbamoyl)-1-hydroxy-ethyl]-3-methyl-butylcarbamoyl}-2-(1H-imidazol-4-yl)-ethylamino]-ethyl}-carbamic acid tert-butyl ester : (0.07 chloroform) CHEMBL168261 BDBM50016056
  • Phosphinic Peptide Inhibitor, 28 FII 2-benzyl-3-{[1-(2-acetamido-4-methylpentanoyl)pyrrolidin-2-yl](hydroxy)phosphoryl}propanoic acid The second fraction of the HPLC chromatogram. BDBM21464
  • BDBM567799 US11420968, Example 8 from CN106749233A
  • BDBM362180 US10272077, Example 8 from US 2010/0179166 US9833448, Example 10 from U.S. Pat. No. 7,390,798
  • US9833448, Example 8 from US 2010/0179166 BDBM362181 US10272077, Example 32 from U.S. Pat. No. 7,390,798
  • BDBM362178 US9833448, Example 8 from U.S. Pat. No. 7,390,798 US10272077, Example 8 from U.S. Pat. No. 7,390,798
  • BDBM362179 US10272077, Example 9 from U.S. Pat. No. 7,390,798 US9833448, Example 9 from U.S. Pat. No. 7,390,798
  • 2-benzyl-3-({1-[2-acetamido-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl}(hydroxy)phosphoryl)propanoic acid Phosphinic Peptide Inhibitor, 34 FII The second fraction of the HPLC chromatogram. BDBM21470
  • 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A US10975057, Example 59 BDBM491775
  • BDBM491776 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction B US10975057, Example 60
  • BDBM491777 US10975057, Example 61 4-Chloro-1-ethyl-5-(4-methoxy-6-((3-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A
  • BDBM491778 US10975057, Example 62 4-Chloro-1-ethyl-5-(4-methoxy-6-((3-(trifluoromethyl)cyclohexyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction B
  • BDBM491786 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclobutyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction B US10975057, Example 72
  • US10975057, Example 77 BDBM491789 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclopropyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A
  • US10975057, Example 78 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclopropyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction B BDBM491790
  • BDBM621058 US20230303556, Example 89 from WO2021/055744
  • BDBM621059 US20230303556, Example 102 from WO2021/055744
  • BDBM621060 US20230303556, Example 24 from WO2021/055744
  • BDBM621061 US20230303556, Example 43 from WO2021/055744
  • BDBM621063 US20230303556, Example 83 from WO2021/055744
  • US20230303556, Example 35 from WO2021/055744 BDBM621062
  • US20230303556, Example 82 from WO2021/055744 BDBM621056
  • US20230303556, Example 88 from WO2021/055744 BDBM621057
  • 3-{[1-(2-acetamido-4-methylpentanoyl)pyrrolidin-2-yl](hydroxy)phosphoryl}-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoic acid The second fraction of the HPLC chromatogram. BDBM21473 Phosphinic Peptide Inhibitor, 40 FII
  • BDBM491785 4-Chloro-1-ethyl-5-(4-methoxy-6-((2-(trifluoromethyl)cyclobutyl)amino)pyridin-3-yl)-N-(((1r,4r)-4-(methylsulfonyl)cyclohexyl)methyl)-1H-pyrazole-3-carboxamide, Fraction A US10975057, Example 72 US10975057, Example 71
  • US20240199576, Example Table 3 from WO 2016/049165 (isomer 1) BDBM681440 US20240199576, Example Table 3 from WO 2016/049165 (isomer 2)